For The Latest Medical News, Health News, Research News, COVID-19 News, Pharma News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Thailand Cannabis News, Cancer News, Doctor News, Thailand Hospital News, Oral Cancer News, Thailand Doctors

BREAKING NEWS
Source: COVID-19 Drugs  Jul 09, 2020  5 years, 5 months, 3 weeks, 2 days, 17 hours, 31 minutes ago

COVID-19 Drugs: Coronavir, A New Antiviral To Treat COVID-19 Approved For Use By Regulatory Agency in Russia

COVID-19 Drugs: Coronavir, A New Antiviral To Treat COVID-19 Approved For Use By Regulatory Agency in Russia
Source: COVID-19 Drugs  Jul 09, 2020  5 years, 5 months, 3 weeks, 2 days, 17 hours, 31 minutes ago
COVID-19 Drugs: R-Pharm, a Russian pharmaceutical company has secured regulatory approval for the use of its antiviral drug Coronavir, to treat patients suffering from Covid-19. The company released the announcement today to Russian media.


 
The regulatory approval comes after a clinical trial in mild to moderate Covid-19 patients showed that the drug is highly effective in blocking replication of SARS-CoV-2, the novel coronavirus that causes the disease.
 
The Russian biotech and pharma company told media, “Coronavir is one of the first drugs in Russia and in the world that does not tackle the complications caused by SARS-CoV-2, but battles the virus itself.”
 
Clinical study data revealed improvement in 55% of outpatients on day seven of treatment with the drug, compared to 20% of those on standard etiotropic therapy, which targets disease cause instead of symptoms.
 
Furthermore a significant difference was observed at 14 days, added the company. The virus was found to be eliminated in 77.5% of Covid-19 patients by day five of treatment with Coronavir.
 
R-Pharm medical director Dr Mikhail Samsonov told Thailand Medical News via  a phone interview a few hours ago, “Global clinical practice and the clinical study we conducted have confirmed that Coronavir puts a much more rapid stop to the infection as a result of its effective obstruction of the virus’s replication.”
 
Russia’s Central Research Institute of Epidemiology clinical trials head Tatyana Ryzhentsova, the drug entered clinical testing in May and has been used to treat more than 110 outpatients so far.
 
However when asked the constituents or the drug and the way it works and also which journals the studies are published in, there was no answer from the agency nor the company.
 
Thailand Medical News will giving updates on this as more details emerge. In the meantime, for more articles on COVID-19 Drugs, keep on logging to Thailand Medical News.

MOST READ

Dec 31, 2025  2 days ago
Nikhil Prasad
Dec 30, 2025  3 days ago
Nikhil Prasad
Dec 27, 2025  6 days ago
Nikhil Prasad
Dec 25, 2025  8 days ago
Nikhil Prasad
Dec 24, 2025  9 days ago
Nikhil Prasad
Dec 22, 2025  11 days ago
Nikhil Prasad
Dec 21, 2025  12 days ago
Nikhil Prasad
Dec 15, 2025  18 days ago
Nikhil Prasad
Dec 11, 2025  22 days ago
Nikhil Prasad
Dec 10, 2025  23 days ago
Nikhil Prasad
Dec 09, 2025  24 days ago
Nikhil Prasad
Dec 07, 2025  26 days ago
Nikhil Prasad